AlphaFold predicted structure
VEGFC · P49767

Mean pLDDT
73.2/ 100
Confident
419 residues
Confidence breakdown
- Very high(≥ 90)22%
- Confident(70–90)46%
- Low(50–70)12%
- Very low(< 50)20%
AlphaFold (Jumper et al., 2021) · CC BY 4.0
vascular endothelial growth factor C
Annotations refreshed 9 hours ago.
Diagnostic Grade (Green)
Fetal anomalies
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownPrimary lymphoedema
MONOALLELIC, autosomal or pseudoautosomal, imprinted status unknownMilroy disease
hypothyroidism
Abnormality of the skeletal system
thyroid gland disorder
neurodegenerative disease
diabetic macular edema
Alzheimer disease
macular retinal edema
retinal vein occlusion
choroidal neovascularization
Score is the Open Targets composite evidence score (0-1). Higher = stronger gene-disease association.
Vascular endothelial growth factor C
Growth factor active in angiogenesis, and endothelial cell growth, stimulating their proliferation and migration and also has effects on the permeability of blood vessels. May function in angiogenesis of the venous and lymphatic vascular systems during embryogenesis, and also in the maintenance of differentiated lymphatic endothelium in adults. Binds and activates KDR/VEGFR2 and FLT4/VEGFR3 receptors
VEGFC · P49767

Mean pLDDT
73.2/ 100
Confident
419 residues
Confidence breakdown
AlphaFold (Jumper et al., 2021) · CC BY 4.0